Rare
lephants
Screener
Toggle theme
CASI Pharmaceuticals, Inc.
CASIF
·
Healthcare, Drug Manufacturers - General, China
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Returns on Capital
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Returns on Capital
Chart
Table
ROE
ROI
ROA
Fiscal Year
ROE
ROI
ROA
FY2024
-2,120.9%
-2,120.9%
-73.1%
FY2025
128.9%
128.9%
-187.4%
Download CSV
